DrugsControl Media Services

News Detail

DCGI initiates investigation on antipsychotic drug 'Restonorm' manufactured without permission (06-05-2023)

New Delhi, 6 May 2023: The National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling price of antipsychotic drug risperidone injection (long acting) 25 mg in its latest meeting after deferring the price fixation earlier due to a dispute raised by multinational pharma......
View Details

Source : Pharmabiz
NPPA antipsychotic drug risperidone injection Johnson & Johnson J&J DCGI Restonorm HFA Formulations Aleteus Biogenics schizophrenia Schedule I Drugs (Prices Control) Order 2013 Risperdal Consta CDSCO DPCO 2013 drugscontrol

Related News